Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Selexipag [USAN:INN]
RN: 475086-01-2
UNII: 5EXC0E384L
InChIKey: QXWZQTURMXZVHJ-UHFFFAOYSA-N

Notes

  • Manufacturers Label: UPTRAVI is indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of hospitalization for PAH.
  • Prostacyclin receptor agonist.

Molecular Formula

  • C26-H32-N4-O4-S

Molecular Weight

  • 496.6288
 

Classification Codes

  • Antihypertensive Agents
  • Cardiovascular Agents
  • Selective non-prostanoid IP prostacyclin receptor agonist.
  • Treatment of Pulmonary Arterial Hypertension
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Selexipag
  • Selexipag [USAN:INN]

Synonyms

  • 2-(4-((5,6-Diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy}-n-(methanesulfonyl)acetamide
  • ACT 293987
  • ACT-293987
  • NS 304
  • NS-304
  • Selexipag
  • UNII-5EXC0E384L
  • Uptravi

Registry Numbers

CAS Registry Number

  • 475086-01-2

FDA UNII

  • 5EXC0E384L

System Generated Number

  • 0475086012

Structure Descriptors

InChI

1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)

InChIKey

QXWZQTURMXZVHJ-UHFFFAOYSA-N

Smiles

CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)c1cnc(c(n1)c2ccccc2)c3ccccc3